Yucca Health GLP 1

Product Details

Yucca Health describes its service as a telehealth platform connecting patients with licensed providers and pharmacies for personalized compounded treatments.

What Is Yucca Health GLP-1?

Yucca Health GLP-1 is a prescription semaglutide treatment provided through an online healthcare programme. It is supplied as a compounded injectable medication and is generally administered once weekly under the guidance of a licensed healthcare provider. The programme is designed to provide a convenient telehealth-based approach to prescription weight management.

Semaglutide belongs to the GLP-1 receptor agonist class and supports appetite regulation and feelings of fullness. Yucca Health positions its programme around personalised dosing, provider oversight, and ongoing telehealth support throughout treatment. Eligibility, dosage, and treatment decisions are determined through an individual review by a licensed provider based on the patient’s health and treatment needs.

Who May Consider Yucca Health GLP-1?

Yucca Health’s programme may be considered by adults seeking provider-guided weight-management care who meet applicable clinical criteria. The service describes eligibility based on factors such as BMI, medical history, current health status, medications, and individual treatment goals. This assessment helps providers determine whether the programme is appropriate for the individual.

People with ongoing, unexplained, or concerning symptoms should seek appropriate medical evaluation rather than relying solely on an online treatment programme. A licensed provider reviews the individual’s health information and medical history before prescribing treatment, helping determine whether semaglutide is suitable and whether any additional precautions or monitoring may be needed.

How May Yucca Health GLP-1 Support General Wellness?

Semaglutide is a GLP-1 receptor agonist that interacts with GLP-1 receptors involved in appetite regulation and glucose-related physiological processes. Yucca Health describes the treatment as supporting fullness and appetite management as part of a provider-guided weight-management approach.

The treatment may support reduced appetite and increased feelings of fullness. It is also associated with slower gastric emptying. These effects relate to semaglutide’s pharmacological action and should not be interpreted as a guarantee of a particular individual outcome.

Provider oversight allows dosing to be adjusted according to individual response and tolerability. The program also provides access to a patient portal for treatment information and communication with the care team.

Supplement Facts

Yucca Health GLP-1 is a prescription compounded medication rather than a dietary supplement, so a conventional Supplement Facts panel is not publicly provided on the treatment page.

• Active medication: Semaglutide
• Dosage form: Subcutaneous injection
• Administration: Once weekly
• Starting dose shown: 0.25 mg weekly
• Titration levels shown: 0.5 mg, 1 mg, 1.7 mg
• Maximum dose shown: 2.4 mg weekly
• Exact vial concentration: Not publicly disclosed
• Vial volume: Not publicly disclosed
• Inactive ingredients/excipients: Not publicly disclosed in the available product information

Each dose level lasts at least four weeks under the standard schedule, although the provider may keep a patient at a dose level longer depending on response and tolerability.

Active Ingredients

The primary active medication is semaglutide, a GLP-1 receptor agonist used within provider-guided weight-management care.

Semaglutide

Semaglutide is a synthetic GLP-1 receptor agonist that participates in appetite regulation and glucose-related physiological processes. Yucca Health provides it as a compounded prescription injection with individualized provider-guided dosing.

Potential Benefits

• Support appetite regulation: Semaglutide may help regulate appetite, which can support healthier eating patterns as part of a weight-management plan.
• Increase feelings of fullness: It may promote greater satiety after meals, potentially helping individuals feel satisfied for longer.
• Contribute to slower gastric emptying: Semaglutide can slow the movement of food through the stomach, which may contribute to prolonged feelings of fullness.
• Provides provider-guided treatment: The programme offers prescription semaglutide with clinical evaluation and guidance from a licensed healthcare provider.
• Supports personalised dosing and telehealth care: Treatment can be tailored to individual needs, with ongoing telehealth support to help monitor progress and adjust care when appropriate.

Important Limitations

• The finished compounded formulation does not have a publicly available Supplement Facts panel.
• Exact vial concentration and inactive-ingredient quantities are not publicly disclosed.
• Individual dosing and treatment decisions require licensed provider oversight.

How to Use?

Yucca Health GLP-1 comes in a compounded injectable form administered subcutaneously.

• The treatment is administered once weekly.
• The standard displayed schedule begins at 0.25 mg weekly.
• The displayed titration levels are 0.5 mg, 1 mg, 1.7 mg, and 2.4 mg.
• Each dose level lasts at least four weeks under the standard schedule.
• Follow the dosing instructions provided by the prescribing healthcare provider rather than changing the dose independently.

After delivery, the medication should be refrigerated at 36–46°F (2–8°C) and should not be frozen.

Warnings and Precautions

• Semaglutide should not be used by people with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2.
• Do not use it if you have previously experienced a severe allergic reaction to semaglutide or one of its ingredients.
• Discuss pregnancy, planned pregnancy, or breastfeeding with your healthcare provider; Yucca Health states that semaglutide is not recommended during pregnancy or breastfeeding.
• Tell your provider about prescription medicines, over-the-counter medicines, vitamins, and supplements.
• Discuss existing pancreas, kidney, or diabetic-retinopathy conditions with your provider.
• Seek medical attention for serious symptoms such as severe abdominal pain, significant allergic reactions, or concerning changes in mood.
• Store the medication refrigerated at 36–46°F (2–8°C) and do not freeze.
• Do not use a vial showing cloudiness, visible particles, discoloration, or a broken seal.

Possible Side Effects and Interactions

Tolerance to semaglutide can vary between individuals. Reported common effects include nausea, constipation, diarrhea, appetite changes, abdominal discomfort, headache, fatigue, and dizziness. Low blood sugar may occur, particularly with insulin or sulfonylurea use. Discuss medications and existing conditions with a healthcare professional before treatment.

Manufacturing and Quality Information

• Manufacturer/distributor: Brand Merchants Network LLC, doing business as Yucca Health.
• Pharmacy fulfillment: Prescriptions are fulfilled by licensed U.S. pharmacies.
• Manufacturing location: The product is described as compounded in the United States.
• Certificate of analysis: Available on request through the pharmacy fulfillment process.

Pros

• Convenient once-weekly injection schedule: A simple weekly routine for ongoing treatment.
• Provider-guided dose progression: Dosing adjustments are made under licensed provider supervision.
• Licensed U.S. pharmacy fulfillment: Prescriptions are fulfilled through licensed U.S. pharmacy partners.
• Free provider consultation and injection kit: Includes consultation support and an injection kit for convenience.
• Patient portal and ongoing provider communication: Provides convenient access to the care team and treatment support.

Cons

• Exact formulation concentration is not publicly disclosed.
• The treatment requires a prescription and provider evaluation.
• The program currently ships only within the United States.

Pricing Options

Yucca Health currently provides several semaglutide payment options, with pricing based on the selected plan and commitment period.

• 6-Month Plan: $750 total, $125 per month.
• 3-Month Plan: $420 total, $140 per month.
• Monthly Plan: $146 per month.

Pricing remains the same across dose levels, with free shipping, provider consultation, and an injection kit included. The monthly plan is described as flexible with no commitment, while subscription plans may renew automatically according to the selected checkout interval.

Pricing and availability were checked on August 27, 2026 and may change on the official website.

Pharmacist Note

When considering semaglutide, review the complete medication and supplement list with your healthcare professional. This helps identify overlapping ingredients, potential interactions, and relevant health considerations. Follow the prescribed dosing instructions and contact your care team about unexpected or concerning symptoms.

Frequently Asked Questions

1. What type of product is Yucca Health GLP-1?

It is a prescription compounded semaglutide medication supplied as a once-weekly subcutaneous injection through Yucca Health’s telehealth program.

2. How should Yucca Health GLP-1 be taken?

Semaglutide is administered once weekly by subcutaneous injection, with the specific dose determined and adjusted by the prescribing provider.

3. How long does one dose level last?

Each dose level lasts at least four weeks under the standard schedule, although providers may maintain a dose longer.

4. Can it be taken with prescription medication?

Patients should tell their provider about all prescription medicines, over-the-counter products, vitamins, and supplements before treatment.

5. Is it suitable during pregnancy or breastfeeding?

Yucca Health’s safety information states that semaglutide is not recommended during pregnancy or breastfeeding and should be discussed with a provider.

6. Where can Yucca Health GLP-1 be purchased?

Treatment is obtained through Yucca Health following online intake, provider evaluation, prescription approval, and licensed pharmacy fulfillment.

Medical Disclaimer

“These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease. Consult a qualified healthcare professional before using a dietary supplement, particularly if you are pregnant, breastfeeding, taking medication or managing a medical condition.”

Sources and Product Review Information

• Official product page: Yucca Health GLP-1 (Semaglutide)
• Safety information: Yucca Health Semaglutide Safety Information
• Shipping information: Yucca Health Shipping Policy
• Official company information: Yucca Health About Us
• Product information checked: August 27, 2026

Affiliate Disclosure: This page may contain affiliate links. If you make a purchase through one of these links, we may earn a commission at no additional cost to you. This does not influence the information presented above, which is based on publicly available product and label information.